The Foundation for the Horse has awarded $110,277 for six innovative equine research projects. “Scientific discovery and innovation bring the future of equine medicine into reality,” said Dr. Anthony Blikslager of The Foundation’s Research Review Group. The supported research projects are follow: Dual licensing of mesenchymal stem cells to enhance tendon healing (TERF sponsored) Dr. Drew W. Koch, North Carolina State University; In vitro analysis of the optimization of stem cell therapy for the treatment of osteoarthritis using equine synovial fluid derived from mesenchymal stem cells with a soluble epoxide hydrolase inhibitor (TERF sponsored) Dr. Alexandra Carlson, University of Tennessee; Clinical evaluation of a rapid test strip, PCR, and enriched-aerobic culture for the detection of salmonella enterica in equine feces Dr. Emily Herring, University of Georgia; Short-term oil dietary supplementation affects oocyte and cumulus cell metabolism in old mares Dr. Giovana Di Donato Catandi, Colorado State University; A pilot study on an experimental model for Palmar Osteochondral Disease (POD) in horses (TERF sponsored) Dr. Lauren Smanik, Colorado State University; Investigation of MARCKS protein as a novel therapeutic target to decreased neutrophil extracellular traps (NETs) in equine asthma Dr. Bethanie L. Cooper, North Carolina State University. Equine research is one of three pillars of impact—along with education and horses at risk—supported by The Foundation. The 2023 application window for this research grant program will open early next year.